Welcome to our dedicated page for Manhattan Associates SEC filings (Ticker: MANH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Manhattan Associates Inc. filings document operating results, governance and executive compensation for a Georgia-incorporated supply chain and omnichannel commerce software company. Form 8-K reports furnish quarterly earnings releases and discuss GAAP results alongside adjusted operating income, adjusted net income and adjusted diluted earnings per share.
The company’s regulatory record also includes current reports on officer succession and related compensation arrangements, including restricted stock units and executive employment terms. Its definitive proxy materials cover board and shareholder matters, executive pay tables, equity awards and pay-versus-performance disclosures.
MORAN CHARLES E reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Charles E. Moran reported an equity award and updated holdings. He received a grant of 1,940 shares of Common Stock at $0.0000 per share as a compensation-related award, lifting his direct holdings to 3,270 shares. The award is a restricted stock unit grant under the company’s stock incentive plan, vesting fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Moran also reported 20,808 shares held indirectly by a trust, reflecting his indirect ownership position.
Capel Eddie reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Eddie Capel received 1,940 shares of Common Stock as a restricted stock unit grant. The award was made at no cash cost per share as part of the company’s stock incentive plan. Following this grant, Capel directly holds 156,329 shares of the company’s common stock.
The restricted stock units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date, aligning director compensation with shareholder interests over that period.
Manhattan Associates, Inc. reported the results of its 2026 Annual Meeting of Shareholders. As of the March 18, 2026 record date, 59,162,073 common shares were entitled to vote, and 55,764,873 shares were present in person or by proxy, representing about 94% participation.
Shareholders elected Class I directors Eddie Capel, Charles E. Moran, and Linda T. Hollembaek to terms expiring in 2029. They also approved, on a non-binding basis, the compensation of the named executive officers, ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved the First Amendment to the company’s 2020 Equity Incentive Plan.
MANHATTAN ASSOCIATES INC: T. Rowe Price Investment Management, Inc. reports beneficial ownership of 3,544,480 shares of Common Stock, equal to 5.9% of the class as of 03/31/2026. The filing lists sole voting power of 3,534,123 shares and includes a statement denying beneficial ownership.
Manhattan Associates Schedule 13G: AQR Capital Management reports beneficial ownership of 3,162,052 shares of Common Stock, representing 5.28% of the class as of 03/31/2026. The filing shows shared voting power of 3,090,463 shares. Filers are AQR Capital Management, LLC and parent AQR Capital Management Holdings, LLC; AQR LLC is a wholly owned subsidiary. The form was signed on 05/14/2026.
Vanguard Capital Management reported beneficial ownership of 3,140,251 shares of Manhattan Associates Inc common stock, representing 5.24% of the class. The filer reports sole voting power for 457,644 shares and sole dispositive power for 3,140,251 shares. The filing is signed by Ashley Grim on 04/30/2026.
Manhattan Associates Inc: Vanguard Portfolio Management reports beneficial ownership of 3,885,253 shares of Common Stock, representing 6.49% of the class as of 03/31/2026. The filing shows sole dispositive power over 3,885,253 shares and sole voting power over 15,504 shares. The Schedule 13G disclosure is signed on 04/29/2026.
Manhattan Associates EVP James Stewart Gantt sold company stock in an open-market transaction. He sold 7,300 shares of Common Stock at an average price of $139.25 per share on April 24, 2026. After this sale, he directly holds 60,815 shares of Manhattan Associates common stock.
MANH-related Form 144 filing reports an intended sale of 7,300 shares of Common Stock. The filing links these shares to restricted stock vesting under a registered plan on 01/31/2026 and shows a sale filing date of 04/24/2026. The entry lists a value of $1,016,525.00 and an adjacent figure of 59,164,602 shares.